AAAAAA

   
Results: 1-9 |
Results: 9
INTENSIVE INDUCTION-SEQUENTIAL CHEMOTHERAPY WITH BOP VIP-B COMPARED WITH TREATMENT WITH BEP/EP FOR POOR-PROGNOSIS METASTATIC NONSEMINOMATOUS GERM-CELL TUMOR - A RANDOMIZED MEDICAL-RESEARCH-COUNCIL EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER STUDY/
Authors: KAYE SB MEAD GM FOSSA S CULLEN M DEWIT R BODROGI I VANGROENINGEN C SYLVESTER R COLLETTE L STENNING S DEPRIJCK L LALLEMAND E DEMULDER P
Citation: Sb. Kaye et al., INTENSIVE INDUCTION-SEQUENTIAL CHEMOTHERAPY WITH BOP VIP-B COMPARED WITH TREATMENT WITH BEP/EP FOR POOR-PROGNOSIS METASTATIC NONSEMINOMATOUS GERM-CELL TUMOR - A RANDOMIZED MEDICAL-RESEARCH-COUNCIL EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER STUDY/, Journal of clinical oncology, 16(2), 1998, pp. 692-701
FILGRASTIM DURING COMBINATION CHEMOTHERAPY OF PATIENTS WITH POOR-PROGNOSIS METASTATIC GERM-CELL MALIGNANCY
Authors: FOSSA SD KAYE SB MEAD GM CULLEN M DEWIT R BODROGI I VANGROENINGEN CJ DEMULDER PHM STENNING S LALLEMAND E DEPRIJCK L COLLETTE L
Citation: Sd. Fossa et al., FILGRASTIM DURING COMBINATION CHEMOTHERAPY OF PATIENTS WITH POOR-PROGNOSIS METASTATIC GERM-CELL MALIGNANCY, Journal of clinical oncology, 16(2), 1998, pp. 716-724
PRE-AND POSTOPERATIVE CHEMOTHERAPY FOR RESECTABLE GASTRIC ADENOCARCINOMA
Authors: BANCEWICZ J GIRLING D ALLUM W CUNNINGHAM D STENNING S
Citation: J. Bancewicz et al., PRE-AND POSTOPERATIVE CHEMOTHERAPY FOR RESECTABLE GASTRIC ADENOCARCINOMA, Annals of the Royal College of Surgeons of England, 80(1), 1998, pp. 73-73
MULTIVARIATE ANALYSES OF DNA INDEX, P62(C-MYC), AND CLINICOPATHOLOGICAL STATUS OF PATIENTS WITH OVARIAN-CANCER
Authors: CURLING M STENNING S HUDSON CN WATSON JV
Citation: M. Curling et al., MULTIVARIATE ANALYSES OF DNA INDEX, P62(C-MYC), AND CLINICOPATHOLOGICAL STATUS OF PATIENTS WITH OVARIAN-CANCER, Journal of Clinical Pathology, 51(6), 1998, pp. 455-461
WHAT IS THE ROLE OF RADIATION-CHEMOTHERAPY IN THE RADICAL NONSURGICALMANAGEMENT OF CARCINOMA OF THE ESOPHAGUS
Authors: PRICE P HOSKIN PJ HUTCHINSON T STENNING S
Citation: P. Price et al., WHAT IS THE ROLE OF RADIATION-CHEMOTHERAPY IN THE RADICAL NONSURGICALMANAGEMENT OF CARCINOMA OF THE ESOPHAGUS, British Journal of Cancer, 78(4), 1998, pp. 504-507
IDENTIFYING MOLECULAR MARKERS PREDICTIVE OF SURVIVAL AND BENEFIT FROMADJUVANT 5-FLUOROURACIL IN COLON-CANCER
Authors: BARRATT PL SEYMOUR MT STENNING S JOEL SP QUIRKE P
Citation: Pl. Barratt et al., IDENTIFYING MOLECULAR MARKERS PREDICTIVE OF SURVIVAL AND BENEFIT FROMADJUVANT 5-FLUOROURACIL IN COLON-CANCER, British Journal of Cancer, 78, 1998, pp. 5-5
SURVIVAL FOLLOWING TREATMENT WITH RMP-7 AND CARBOPLATIN IN MALIGNANT GLIOMA WHO GRADE III-IV - COMPARISON WITH MATCHED CONTROLS
Authors: OSBORN C STENNING S DOWNING G
Citation: C. Osborn et al., SURVIVAL FOLLOWING TREATMENT WITH RMP-7 AND CARBOPLATIN IN MALIGNANT GLIOMA WHO GRADE III-IV - COMPARISON WITH MATCHED CONTROLS, European journal of cancer, 33, 1997, pp. 902-902
IMPROVING THE ACCEPTABILITY OF HIGH-DOSE RADIOTHERAPY BY REDUCING THEDURATION OF TREATMENT - ACCELERATED RADIOTHERAPY IN HIGH-GRADE GLIOMA
Authors: BRADA M THOMAS G ELYAN S JAMES N HINES F ASHLEY S MARSH H BELL BA STENNING S
Citation: M. Brada et al., IMPROVING THE ACCEPTABILITY OF HIGH-DOSE RADIOTHERAPY BY REDUCING THEDURATION OF TREATMENT - ACCELERATED RADIOTHERAPY IN HIGH-GRADE GLIOMA, British Journal of Cancer, 71(6), 1995, pp. 1330-1334
INITIAL CHEMOTHERAPY FOR STAGE-II TESTICULAR NONSEMINOMA
Authors: HORWICH A STENNING S
Citation: A. Horwich et S. Stenning, INITIAL CHEMOTHERAPY FOR STAGE-II TESTICULAR NONSEMINOMA, World journal of urology, 12(3), 1994, pp. 148-150
Risultati: 1-9 |